References
- Alrezk R, Suarez A, Tena I, Pacak K. Update of pheochromocytoma syndromes: genetics, biochemical evaluation, and imaging. Front Endocrinol (Lausanne) 9, 515, 2018.10.3389/fendo.2018.00515627748130538672
- Baguet JP, Hammer L, Mazzuco TL, Chabre O, Mallion JM, Sturm N, Chaffanjon P. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol 150, 681–686, 2004.10.1530/eje.0.150068115132724
- Bean L, Bayrak-Toydemir P. American College of Medical Genetics and Genomics Standards and Guidelines for Clinical Genetics Laboratories, 2014 edition: technical standards and guidelines for Huntington disease. Genet Med 16, e2, 2014.10.1038/gim.2014.14625356969
- Berends AMA, Buitenwerf E, de Krijger RR, Veeger NJGM, van der Horst-Schrivers ANA, Links TP, Kerstens MN. Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: A nationwide study and systematic review. Eur J Intern Med 51, 68–73, 2018.10.1016/j.ejim.2018.01.01529361475
- Chew WHW, Courtney E, Lim KH, Li ST, Chen Y, Tan MH, Chung A, Khoo J, Loh A, Soh SY, Iyer P, Loh LM, Ngeow J. Clinical management of pheochromocytoma and paraganglioma in Singapore: missed opportunities for genetic testing. Mol Genet Genomic Med 5, 602–607, 2017.10.1002/mgg3.313560687928944243
- Cornu E, Belmihoub I, Burnichon N, Grataloup C, Zinzindohoue F, Baron S, Billaud E, Azizi M, Gimenez-Roqueplo AP, Amar L. Pheochromocytome et paragangliome [Phaeochromocytoma and paraganglioma]. Rev Med Interne 40, 733–741, 2019.10.1016/j.revmed.2019.07.00831493938
- Davison AS, Jones DM, Ruthven S, Helliwell T, Shore SL. Clinical evaluation and treatment of phaeochromocytoma. Ann Clin Biochem 55, 34–48, 2018.10.1177/000456321773993129027806
- Fishbein L. Pheochromocytoma/paraganglioma: Is this a genetic disorder? Curr Cardiol Rep 21, 104, 2019.10.1007/s11886-019-1184-y31367972
- Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr; Endocrine Society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99, 1915–1942, 2014.10.1210/jc.2014-149824893135
- Mannelli M. Biochemistry, genetics and therapy of malignant pheochromocytomas. Ann Endocrinol (Paris) 70, 166–167, 2009.10.1016/j.ando.2009.02.00919286155
- Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C; Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346, 1459–1466, 2002.10.1056/NEJMoa02015212000816
- Walther MM, Reiter R, Keiser HR, Choyke PL, Venzon D, Hurley K, Gnarra JR, Reynolds JC, Glenn GM, Zbar B, Linehan WM. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 162, 659–664, 1999.10.1097/00005392-199909010-0000410458336
- WHO Classification of Tumours of Endocrine Organs, WHO Classification of Tumours, 4th Edition, Volume 10 (Eds. Lloyd RV, Osamura RY, Kloppel G, Rosai J), 2017.